MarkNtel Advisors, a leading market research and consulting firm, has announced the release of its latest study titled Colorectal Cancer (CRC) Diagnostics and Treatments Market Research Report: Forecast (2025–2030). This report provides a detailed assessment of the Colorectal Cancer (CRC) Diagnostics and Treatments Market, covering its evolving dynamics, emerging trends, key growth drivers, major challenges, and competitive landscape.
Designed to guide investors, stakeholders, and business leaders, the research aims to deliver valuable insights for strategic planning, risk assessment, and investment decision-making in the years ahead.
Market Timeline Overview
- Historical Years: 2020-23
- Base Years: 2024
- Forecast year - 2025-2030
This helps businesses identify emerging opportunities, assess market risks, and develop data-driven strategies for long-term success.
Download a FREE PDF Sample of the Report: https://www.marknteladvisors.com/query/request-sample/colorectal-cancer-crc-market.html (Discover the market potential, platform-specific insights, and key industry trends.)
Colorectal Cancer (CRC) Diagnostics and Treatments Market Outlook
According to the report Colorectal Cancer (CRC) Diagnostics and Treatments Market size was valued at around USD10.89 Billion in 2024 and is projected to reach USD16.89 Billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 7.6% during the forecast period, i.e., 2025-30.
The report also examines consumer preferences, regulatory impacts, and investment trends that will shape the market’s trajectory over the next decade.
In case you missed it, we're currently updating our reports. Click below to access a free PDF sample of the latest research, featuring forecasts from 2026 to 2032. The report includes market size, industry trends, and competitive analysis. Our team will promptly deliver the most recent version to you.
Colorectal Cancer (CRC) Diagnostics and Treatments Market Drivers:
High Ubiquity of Colorectal Cancer Driving Demand – Globally, colorectal cancer is a major health concern. 930,000 people died and 10. 9 million new cases were reported worldwide in 2020. The number of cases is expected to increase to 32. 2 million by 2040, with 12. 6 million expected deaths. The disease is most common in countries with high or extremely high HDI. With 10% of cases worldwide, it is the second most common cause of cancer-related deaths and the third most common type of cancer overall. Different geographic prevalence rates indicate that colorectal cancer (CRC) is most common in Australia, New Zealand, and Europe, while it is less common in some parts of Africa and Southern Asia.
View Full Report (All Data, In One Place): https://www.marknteladvisors.com/research-library/colorectal-cancer-crc-market.html (Explore in-depth analyses, technological trends, and investment patterns.)
Colorectal Cancer (CRC) Diagnostics and Treatments Market Trends:
Integration of Multiomics Approaches – The incorporation of multiomics strategies is shaping the global market. It integrates various omics to provide a more in-depth molecular understanding of colorectal cancer. The use of these approaches improves the ability to diagnose and personalize treatment for colorectal cancer by establishing new cancer biomarkers and therapeutic targets. The United States, Germany, and China have established themselves as researchers in this domain. For instance, a study published in Molecular Cancer demonstrated a multiomics-based blood test to provide high sensitivity when detecting early-stage CRC, including sensitivities of 80% for stage I and 89.2% for stage II.
Colorectal Cancer (CRC) Diagnostics and Treatments Market Segmentation
The study categorizes the Colorectal Cancer (CRC) Diagnostics and Treatments Market into various segments and sub-segments, each analyzed for its size, growth potential, and contribution to the overall industry.
By Diagnosis
- Blood & Stool Tests
- Imaging
- Biopsy
- Flexible Sigmoidoscopy
- Colonoscopy
By Treatment
- Chemotherapy
- Alkylating Agents
- Antimetabolites
- Fluorouracil
- Capecitabine
- Others
- Immunotherapy
- Monoclonal Antibodies
- Bevacizumab
- Cetuximab
- Panitumumab
- Biologic Response Modifiers
- Colony-Stimulating Factors
- Tumor Vaccines
- Monoclonal Antibodies
- Surgery
- Targeted Therapy
- Others (Radiofrequency Ablation (RFA), etc.)
By End-User
- Hospitals
- Specialty Clinics
- Others (Ambulatory Surgery Centers, etc.)
Geographical Analysis
The report presents detailed insights into the market’s geographical expansion, highlighting key trends and opportunities across the following geographies:
By Region
- North America
- South America
- Europe
- Middle East & Africa
- Asia-Pacific
Talk to Our Industry Analyst: https://www.marknteladvisors.com/query/talk-to-our-consultant/colorectal-cancer-crc-market.html Get personalized insights into company strategies and regional market dynamics.)
Leading Companies in Colorectal Cancer (CRC) Diagnostics and Treatments Market Worldwide: Players, Analysis & Future Outlook
- Abbott Laboratories
- Amgen Inc.
- Bayer AG
- Bristol Myers Squibb
- Eli Lilly and Company
- GlaxoSmithKline PLC
- Hoffmann-La Roche AG
- Merck & Co., Inc.
- Novartis International AG
- Pfizer Inc.
- Others
Key Highlights of the Report
- Comprehensive Market Overview: In-depth analysis of market size, share, and forecasts from 2025 to 2030.
- Growth Drivers & Challenges: Clear insights into factors feeling or restraining market expansion.
- Investment & Regulatory Insights: Evaluation of key policies, funding trends, and collaborations influencing industry performance.
- Competitive Landscape: Detailed profiles of leading companies, including product portfolios, business strategies, financials, and recent developments such as mergers & acquisitions.
- Analytical Tools: Application of SWOT Analysis, PESTEL Analysis, and Porter’s Five Forces Model to assess competition and external influences
Browse through our flexible pricing plans and choose the package that best fits your business needs whether you require a single-user license, corporate access, or customized insights. Once you select the plan that suits your requirements, you can purchase and instantly access the full report online – https://www.marknteladvisors.com/pricing/colorectal-cancer-crc-market.html
Frequently Asked Questions (FAQ)
- What is the projected growth rate of the Colorectal Cancer (CRC) Diagnostics and Treatments Market?
2. What are the major factors driving this market’s growth?
3. Which regions are expected to lead the Colorectal Cancer (CRC) Diagnostics and Treatments Market?
4. Who are the prominent players in the Colorectal Cancer (CRC) Diagnostics and Treatments Market?
5. How is the competition structured in this market?
6. How can I access the full report?
About Us
MarkNtel Advisors is a globally recognized market research and consulting firm delivering intelligence across the healthcare industry, spanning pharmaceuticals, medical devices, healthcare IT, and biotechnology. Our analysts combine domain expertise with innovation tracking to help healthcare organizations improve efficiency and patient outcomes. Through Consulting Services, we assist clients in interpreting insights, designing go-to-market strategies, and adapting to regulatory changes, fostering sustainable growth in the evolving global healthcare ecosystem.
Contact Us:
MarkNtel Advisors
Sector 63, Noida, Uttar Pradesh-201301, India
Contact No: +91 87199 99009
Email: sales@marknteladvisors.com
Website: https://www.marknteladvisors.com
Comments (0)